{
  "ticker": "JAT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968633",
  "id": "02968633",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250711",
  "time": "1359",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lqc6ld23n5n0.pdf",
  "summary": "- **FY2025 Unaudited Loss Guidance**: Expected net loss after tax of $7.6M to $8.0M (unaudited), a material decline vs. FY2024.  \n  - Second-half loss: $1.5M to $1.9M (vs. $6.1M loss in 1H FY2025).  \n- **Key Drivers**:  \n  - Revenue decline of ~$39M due to suspension of Neurio sales in China and cessation of international trading operations (partly offset by strong Moroka sales).  \n  - Goodwill impairment of $2.35M (Sunnya) and inventory write-down of $1.4M (Neurio-related).  \n  - Legal costs of $4.1M (Neurio dispute).  \n- **FY2026 Outlook**: Focus on Moroka brand growth; distributor H&S targets $11M sales (+22% vs. FY2025).  \n\n*No other material information identified.*",
  "usage": {
    "prompt_tokens": 1364,
    "completion_tokens": 208,
    "total_tokens": 1572,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-11T04:11:33.423511"
}